Maplight Therapeutics, Inc. · NASDAQ:MPLT
Gillis Jonathan sold 69,835 Maplight Therapeutics, Inc. shares (Form 4)
Traded Apr 27 to Apr 28, 2026 · Filed Apr 29, 2026
From Apr 27 to Apr 28, 2026, Gillis Jonathan (CAAO and PAO) sold 69,835 Maplight Therapeutics, Inc. shares at an average US$29.89 for US$2.09M under a trading plan, leaving 181,219 shares. Filed Apr 29, 2026 (Form 4).
- Sold
- 69,835 shares
- Price
- US$29.89 average (US$28.94 to US$30.83)
- Value
- US$2.09M
- Holding after
- 181,219 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CAAO and PAO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Voting Common Stock | Sale | 7,914 | US$28.94 | 243,140 | Direct |
| Apr 27, 2026 | Voting Common Stock | Sale | 29,623 | US$29.60 | 213,517 | Direct |
| Apr 27, 2026 | Voting Common Stock | Sale | 14,363 | US$30.46 | 199,154 | Direct |
| Apr 28, 2026 | Voting Common Stock | Sale | 17,235 | US$30.33 | 181,919 | Direct |
| Apr 28, 2026 | Voting Common Stock | Sale | 700 | US$30.83 | 181,219 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Gillis Jonathan
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Gillis Jonathan · Aug 19, 2026
- Form 4 · Gillis Jonathan · Jul 20, 2026
- Form 4 · Gillis Jonathan · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026